Document Detail


In vitro detoxification of cyclosarin in human blood pre-incubated ex vivo with recombinant serum paraoxonases.
MedLine Citation:
PMID:  21807078     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
An ex vivo protocol was developed to assay the antidotal capacity of rePON1 variants to protect endogenous acetylcholinesterase and butyrylcholinesterase in human whole blood against OP nerve agents. This protocol permitted us to address the relationship between blood rePON1 concentrations, their kinetic parameters, and the level of protection conferred by rePON1 on the cholinesterases in human blood, following a challenge with cyclosarin (GF). The experimental data thus obtained were in good agreement with the predicted percent residual activities of blood cholinesterases calculated on the basis of the rate constants for inhibition of human acetylcholinesterase and butyrylcholinesterase by GF, the concentration of the particular rePON1 variant, and its k(cat)/K(m) value for GF. This protocol thus provides a rapid and reliable ex vivo screening tool for identification of rePON1 bioscavenger candidates suitable for protection of humans against organophosphorus-based toxicants. The results also permitted the refinement of a mathematical model for estimating the efficacious dose of rePON1s variants required for prophylaxis in humans.
Authors:
Yacov Ashani; Moshe Goldsmith; Haim Leader; Israel Silman; Joel L Sussman; Dan S Tawfik
Related Documents :
15972428 - Quantitative assessment of colorectal cancer perfusion using mdct: inter- and intraobse...
9498598 - Quantitation of intrinsic magnetic susceptibility-related effects in a tissue matrix. p...
11907178 - In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese ...
15627078 - In situ eosinophil activation in 26 primary cutaneous t-cell lymphomas with blood eosin...
8678628 - Impact of transfusion of mediastinal shed blood on serum levels of cardiac enzymes.
11552728 - Analytical modeling and numerical simulation of forces in an endoluminal graft.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-23
Journal Detail:
Title:  Toxicology letters     Volume:  -     ISSN:  1879-3169     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-8-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7709027     Medline TA:  Toxicol Lett     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Ireland Ltd.
Affiliation:
Department of Structural Biology, The Weizmann Institute of Science, Kimmelman Bldg, Rm 661, Rehovot 76100, Israel; Department of Neurobiology, The Weizmann Institute of Science, Kimmelman Bldg, Rm 661, Rehovot 76100, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma deve...
Next Document:  Development of an in vitro liver toxicity prediction model based on longer term primary rat hepatocy...